The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...
An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...
The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Researchers at the Children's Cancer Institute and UNSW Sydney have tested a new way of treating childhood brain cancer by ...
Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...
A cheap, widely available diabetes drug may soon pull double duty as a colon cancer-fighting supplement, according to new research that’s turning heads in the medical world. Metformin, a staple ...